Oncology Trials

  • 01/06/2011

    Persephone

    Duration of Trastuzumab with chemotherapy in women with early breast cancer: six months versus twelve

    View Trial
  • 01/04/2017

    BIG 14-01 The AURORA PROGRAM

    Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer

    View Trial
  • 01/01/2025

    ROSCO

    Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer: A randomised phase III stratified biomarker trial of neo-adjuvant 5-Fluorouracil Epirubicin and Cyclophosphamide vs Docetaxel and Cyclophosphamide chemotherapy

    View Trial
  • 01/07/2024

    Add-Aspirin

    A phase III double-blind placebo-controlled randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

    View Trial
  • 30/04/2028

    OPTIMA

    Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis.

    View Trial
  • 01/05/2017

    Neo-excel

    Neoadjuvant trial of pre-operative exemestane or letrozole +/-celecoxib in the treatment of ER positive postmenopausal early breast cancer

    View Trial
  • 01/06/2019

    STAMPEDE

    Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy

    View Trial
  • 30/06/2017

    TUXEDO

    Phase I/II feasibility study of cetuximab with cisplatin or 5FU and Mitomycin C with concurrent radiotherapy in muscle invasive bladder cancer (TUXEDO)

    View Trial
  • 31/12/2017

    UKGPCS

    UK Genetic Prostate Cancer Study

    View Trial
  • 04/02/2012

    A series of local service evaluations to describe the chemotherapy treatment of metastatic hormone refractory prostate cancer (mHRPC)

    View Trial